| Name | Code | URI | Type | Description |
| Not Selectable | notSelectable | http://hl7.org/fhir/concept-properties#notSelectable | boolean | Indicates that the code is abstract - only intended to be used as a selector for other concepts |
| Status | status | http://hl7.org/fhir/concept-properties#status | code | Designation of a concept's state. Normally is not populated unless the state is retired. |
| Not Selectable | notSelectable | http://hl7.org/fhir/concept-properties#notSelectable | boolean | Indicates that the code is abstract - only intended to be used as a selector for other concepts |
| Status | status | http://hl7.org/fhir/concept-properties#status | code | Designation of a concept's state. Normally is not populated unless the state is retired. |
| Specializes | Specializes | | Coding | The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric. |
| Generalizes | Generalizes | | Coding | Inverse of Specializes. Only included as a derived relationship. |
| internalId | internalId | http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id | code | The internal identifier for the concept in the HL7 Access database repository. |
| Lvl | Code | Display | Definition | Not Selectable | Status | Not Selectable | Status | internalId |
| 1 | _ActSubstanceAdminSubstitutionCode | ActSubstanceAdminSubstitutionCode | Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.
| true, true | active, active | true, true | active, active | 21284 |
| 2 | E | equivalent | Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
| | active | | active | 23107 |
| 3 | EC | equivalent composition | Substitution occurred or is permitted with another product that is a:
- pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
- pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
Examples:
- Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
- Pharmaceutical equivalent: Lisonpril for Zestril
| | active | | active | 23108 |
| 4 | BC | brand composition | Substitution occurred or is permitted between equivalent Brands but not Generics
Examples:
- Zestril for Prinivil
- Coumadin for Jantoven
| | active | | active | 23109 |
| 4 | G | generic composition | Substitution occurred or is permitted between equivalent Generics but not Brands
Examples:
- Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
| | active | | active | 16623 |
| 3 | TE | therapeutic alternative | Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
Examples:
| | active | | active | 16624 |
| 4 | TB | therapeutic brand | Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
Examples:
| | active | | active | 23105 |
| 4 | TG | therapeutic generic | Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
Examples:
- Ranitidine for cimetidine
| | active | | active | 23106 |
| 2 | F | formulary | This substitution was performed or is permitted based on formulary guidelines.
| | active | | active | 16625 |
| 2 | N | none | No substitution occurred or is permitted.
| | active | | active | 16622 |
| 2 | E | equivalent | Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
| | active, active | | active, active | 23107, 23107, 23107 |
| 3 | EC | equivalent composition | Substitution occurred or is permitted with another product that is a:
- pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
- pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
Examples:
- Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
- Pharmaceutical equivalent: Lisonpril for Zestril
| | active | | active | 23108 |
| 4 | BC | brand composition | Substitution occurred or is permitted between equivalent Brands but not Generics
Examples:
- Zestril for Prinivil
- Coumadin for Jantoven
| | active | | active | 23109 |
| 4 | G | generic composition | Substitution occurred or is permitted between equivalent Generics but not Brands
Examples:
- Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
| | active | | active | 16623 |
| 3 | TE | therapeutic alternative | Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
Examples:
| | active | | active | 16624 |
| 4 | TB | therapeutic brand | Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
Examples:
| | active | | active | 23105 |
| 4 | TG | therapeutic generic | Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
Examples:
- Ranitidine for cimetidine
| | active | | active | 23106 |
| 3 | EC | equivalent composition | Substitution occurred or is permitted with another product that is a:
- pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
- pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
Examples:
- Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
- Pharmaceutical equivalent: Lisonpril for Zestril
| | active, active | | active, active | 23108, 23108, 23108 |
| 4 | BC | brand composition | Substitution occurred or is permitted between equivalent Brands but not Generics
Examples:
- Zestril for Prinivil
- Coumadin for Jantoven
| | active | | active | 23109 |
| 4 | G | generic composition | Substitution occurred or is permitted between equivalent Generics but not Brands
Examples:
- Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
| | active | | active | 16623 |
| 4 | BC | brand composition | Substitution occurred or is permitted between equivalent Brands but not Generics
Examples:
- Zestril for Prinivil
- Coumadin for Jantoven
| | active, active | | active, active | 23109, 23109, 23109 |
| 4 | G | generic composition | Substitution occurred or is permitted between equivalent Generics but not Brands
Examples:
- Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
| | active, active | | active, active | 16623, 16623, 16623 |
| 3 | TE | therapeutic alternative | Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
Examples:
| | active, active | | active, active | 16624, 16624, 16624 |
| 4 | TB | therapeutic brand | Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
Examples:
| | active | | active | 23105 |
| 4 | TG | therapeutic generic | Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
Examples:
- Ranitidine for cimetidine
| | active | | active | 23106 |
| 4 | TB | therapeutic brand | Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
Examples:
| | active, active | | active, active | 23105, 23105, 23105 |
| 4 | TG | therapeutic generic | Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
Examples:
- Ranitidine for cimetidine
| | active, active | | active, active | 23106, 23106, 23106 |
| 2 | F | formulary | This substitution was performed or is permitted based on formulary guidelines.
| | active, active | | active, active | 16625, 16625, 16625 |
| 2 | N | none | No substitution occurred or is permitted.
| | active, active | | active, active | 16622, 16622, 16622 |